rs10516845

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000345.4(SNCA):​c.307-33850T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 152,236 control chromosomes in the GnomAD database, including 1,942 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1942 hom., cov: 32)

Consequence

SNCA
NM_000345.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.98

Publications

7 publications found
Variant links:
Genes affected
SNCA (HGNC:11138): (synuclein alpha) Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene. [provided by RefSeq, Feb 2016]
SNCA Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • autosomal dominant Parkinson disease 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Lewy body dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • parkinsonian-pyramidal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000345.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNCA
NM_000345.4
MANE Select
c.307-33850T>C
intron
N/ANP_000336.1
SNCA
NM_001146054.2
c.307-33850T>C
intron
N/ANP_001139526.1
SNCA
NM_001146055.2
c.307-33850T>C
intron
N/ANP_001139527.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNCA
ENST00000394991.8
TSL:1 MANE Select
c.307-33850T>C
intron
N/AENSP00000378442.4
SNCA
ENST00000394986.5
TSL:1
c.307-33850T>C
intron
N/AENSP00000378437.1
SNCA
ENST00000394989.6
TSL:1
c.265-33850T>C
intron
N/AENSP00000378440.2

Frequencies

GnomAD3 genomes
AF:
0.123
AC:
18649
AN:
152118
Hom.:
1941
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.133
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.0897
Gnomad EAS
AF:
0.548
Gnomad SAS
AF:
0.261
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.0633
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.123
AC:
18661
AN:
152236
Hom.:
1942
Cov.:
32
AF XY:
0.128
AC XY:
9561
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.133
AC:
5512
AN:
41538
American (AMR)
AF:
0.197
AC:
3011
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0897
AC:
311
AN:
3468
East Asian (EAS)
AF:
0.548
AC:
2838
AN:
5182
South Asian (SAS)
AF:
0.259
AC:
1248
AN:
4818
European-Finnish (FIN)
AF:
0.101
AC:
1075
AN:
10610
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0633
AC:
4306
AN:
68012
Other (OTH)
AF:
0.129
AC:
274
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
773
1546
2319
3092
3865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0620
Hom.:
205
Bravo
AF:
0.134
Asia WGS
AF:
0.398
AC:
1379
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.24
DANN
Benign
0.51
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10516845; hg19: chr4-90684278; API